You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • FRI0257 Quantitative analysis of severe intestinal involvements by serum fibroblast growth factor (FGF) 19 and 13C-fatty acid-breath test in patients with systemic sclerosis

Alerts

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Scleroderma, myositis and related syndromes – clinical aspects and treatment
FRI0257 Quantitative analysis of severe intestinal involvements by serum fibroblast growth factor (FGF) 19 and 13C-fatty acid-breath test in patients with systemic sclerosis
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address